Crescent Biopharma, Inc.

CBIO·NASDAQ·$20.35Share Price as of 11/2·$561MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2607/30/26 10-Q/AQ1 ended 03/31/2606/22/26 10-QQ1 ended 03/31/2604/29/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25

Disclosures

8-KCurrent report10/15/26 8-KCurrent report07/30/26 8-KCurrent report07/15/26 8-KCurrent report07/14/26 8-KCurrent report06/03/26

Prospectuses and Registrations

S-8Registration of securities for employees09/18/26 424B3Prospectus07/30/26 POS AMPost-effective amendment07/30/26 424B5Prospectus supplement07/15/26 424B5Prospectus supplement07/14/26

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26 DEFA14AAdditional proxy materials04/21/26 DEFA14AAdditional proxy materials01/13/25 DEFA14AAdditional proxy materials11/07/24

Ownership

Form 4Insider transaction09/18/26 Form 4Insider transaction09/18/26 Form 4Insider transaction09/18/26 Form 4Insider transaction09/18/26 Form 4Insider transaction09/18/26

Other

EFFECTRequest for effectiveness07/31/26 EFFECTRequest for effectiveness07/10/26 EFFECTRequest for effectiveness03/03/26 EFFECTRequest for effectiveness01/15/26 CORRESPCorrespondence with the SEC01/13/26